drugs

How will weight-loss drugs change our relationship with food?

The rise of these treatments has major implications for how we think about obesity, says James Gallagher.




drugs

Weight loss injections: How do drugs like Wegovy and Mounjaro work?

NHS experts report unprecedented demand for the new generation of obesity treatments.




drugs

Drugs and Organized Crime: The Challenges Facing Southeast Asia




drugs

The war on drugs has failed: doctors should lead calls for drug policy reform




drugs

Cancer drugs remain FDA approved despite lack of benefit, study finds




drugs

A Proven Way To Lose Weight Without Diet, Exercise Or Drugs

Lose weight with no effort using the ripple effect.




drugs

Inquest date set for Atikokan man who overdosed on drugs while in police custody in 2020

A date has been set for an inquest into the circumstances surrounding the death of a 37-year-old man in police custody in Atikokan, Ont. who overdosed while in police custody in October 2020. The incident led to an investigation by the province's Special Investigations Unit.



  • News/Canada/Thunder Bay

drugs

Prateik Babbar Reveals He Started Taking Drugs At Age 13: "Had A Different Upbringing, Family Situation Was Complicated"

Prateik clarified that it was not money and recognition that pushed him into taking drugs, as people often think




drugs

China hits out at US drugs tag

CHINA yesterday urged the United States to stop attacking and slandering the country, following the release of a US presidential memorandum that identified China as one of the major drug transit or illicit




drugs

The surprising mental health and brain benefits of weight-loss drugs

Drugs like Ozempic and Wegovy have unexpected effects on the brain, opening up potential new ways to treat depression, anxiety, addiction and Alzheimer’s




drugs

RA Drugs Linked to Slight Skin Cancer Risk

Title: RA Drugs Linked to Slight Skin Cancer Risk
Category: Health News
Created: 8/30/2007 12:00:00 AM
Last Editorial Review: 8/30/2007 12:00:00 AM




drugs

Are You Driving Your Teen to Alcohol, Drugs?

Title: Are You Driving Your Teen to Alcohol, Drugs?
Category: Health News
Created: 8/27/2009 12:00:00 AM
Last Editorial Review: 8/27/2009 12:00:00 AM




drugs

Heart Risks the Same With 2 Diabetes Drugs: Study

Title: Heart Risks the Same With 2 Diabetes Drugs: Study
Category: Health News
Created: 8/24/2010 6:10:00 PM
Last Editorial Review: 8/25/2010 12:00:00 AM




drugs

Herpes Drugs May Be Safe in Early Pregnancy

Title: Herpes Drugs May Be Safe in Early Pregnancy
Category: Health News
Created: 8/25/2010 11:17:00 AM
Last Editorial Review: 8/25/2010 11:17:09 AM




drugs

Stopping Controversial Asthma Drugs Could Have Downside: Study

Title: Stopping Controversial Asthma Drugs Could Have Downside: Study
Category: Health News
Created: 8/27/2012 6:05:00 PM
Last Editorial Review: 8/28/2012 12:00:00 AM




drugs

U.S. Nursing Homes Reducing Use of Antipsychotic Drugs

Title: U.S. Nursing Homes Reducing Use of Antipsychotic Drugs
Category: Health News
Created: 8/27/2013 4:36:00 PM
Last Editorial Review: 8/28/2013 12:00:00 AM




drugs

Why Aren't Rx Weight-Loss Drugs More in Demand?

Title: Why Aren't Rx Weight-Loss Drugs More in Demand?
Category: Health News
Created: 8/28/2014 11:01:00 AM
Last Editorial Review: 8/28/2014 12:00:00 AM




drugs

Blood Pressure Drugs Linked to Longer Ovarian Cancer Survival

Title: Blood Pressure Drugs Linked to Longer Ovarian Cancer Survival
Category: Health News
Created: 8/24/2015 12:00:00 AM
Last Editorial Review: 8/25/2015 12:00:00 AM




drugs

New Hope From Old Drugs in Fight Against Parkinson's

Title: New Hope From Old Drugs in Fight Against Parkinson's
Category: Health News
Created: 8/31/2017 12:00:00 AM
Last Editorial Review: 9/1/2017 12:00:00 AM




drugs

U.S. Deaths From Suicide, Drugs Surpass Diabetes

Title: U.S. Deaths From Suicide, Drugs Surpass Diabetes
Category: Health News
Created: 8/27/2018 12:00:00 AM
Last Editorial Review: 8/28/2018 12:00:00 AM




drugs

FDA Warns of Liver Problems for Some Taking Hep C Drugs

Title: FDA Warns of Liver Problems for Some Taking Hep C Drugs
Category: Health News
Created: 8/29/2019 12:00:00 AM
Last Editorial Review: 8/29/2019 12:00:00 AM




drugs

For Medicare Patients, Costs of MS Drugs Rise Sevenfold Over 10 Years

Title: For Medicare Patients, Costs of MS Drugs Rise Sevenfold Over 10 Years
Category: Health News
Created: 8/28/2019 12:00:00 AM
Last Editorial Review: 8/29/2019 12:00:00 AM




drugs

Could Electrode 'Pulses' Cut Back, Leg Pain Without Drugs?

Title: Could Electrode 'Pulses' Cut Back, Leg Pain Without Drugs?
Category: Health News
Created: 8/26/2021 12:00:00 AM
Last Editorial Review: 8/27/2021 12:00:00 AM




drugs

High Blood Pressure Drugs (Hypertension)

Title: High Blood Pressure Drugs (Hypertension)
Category: Medications
Created: 8/16/2006 12:00:00 AM
Last Editorial Review: 7/1/2022 12:00:00 AM




drugs

Effects of Compound Probiotics on Pharmacokinetics of Cytochrome 450 Probe Drugs in Rats [Articles]

Compound probiotics have been widely used and commonly coadministered with other drugs for treating various chronic illnesses, yet their effects on drug pharmacokinetics remain underexplored. This study elucidated the impact of VSL#3 on the metabolism of probe drugs for cytochrome P450 enzymes (P450s), specifically omeprazole, tolbutamide, midazolam, metoprolol, phenacetin, and chlorzoxazone. Male Wistar rats were administered drinking water containing VSL#3 or not for 14 days and then intragastrically administered a P450 probe cocktail; this was done to investigate the host P450’s metabolic phenotype. Stool, liver/jejunum, and serum samples were collected for 16S ribosomal RNA sequencing, RNA sequencing, and bile acid profiling. The results indicated significant differences in both α and β diversity of intestinal microbial composition between the probiotic and vehicle groups in rats. In the probiotic group, the bioavailability of omeprazole increased by 269.9%, whereas those of tolbutamide and chlorpropamide decreased by 28.1% and 27.4%, respectively. The liver and jejunum exhibited 1417 and 4004 differentially expressed genes, respectively, between the two groups. In the probiotic group, most of P450 genes were upregulated in the liver but downregulated in the jejunum. The expression of genes encoding metabolic enzymes and drug transporters also changed. The serum-conjugated bile acids in the probiotic group were significantly reduced. Shorter duodenal villi and longer ileal villi were found in the probiotic group. In summary, VSL#3 administration altered the gut microbiota, host drug–processing gene expression, and intestinal structure in rats, which could be reasons for pharmacokinetic changes.

SIGNIFICANCE STATEMENT

This study focused on the effects of the probiotic VSL#3 on the pharmacokinetic profile of cytochrome P450 probe drugs and the expression of host drug metabolism genes. Compared with previous studies, the present study provides a comprehensive explanation for the host drug metabolism profile modified by probiotics, combined here with the bile acid profile and histopathological analysis.




drugs

Quantitatively Predicting Effects of Exercise on Pharmacokinetics of Drugs Using a Physiologically Based Pharmacokinetic Model [Articles]

Exercise significantly alters human physiological functions, such as increasing cardiac output and muscle blood flow and decreasing glomerular filtration rate (GFR) and liver blood flow, thereby altering the absorption, distribution, metabolism, and excretion of drugs. In this study, we aimed to establish a database of human physiological parameters during exercise and to construct equations for the relationship between changes in each physiological parameter and exercise intensity, including cardiac output, organ blood flow (e.g., muscle blood flow and kidney blood flow), oxygen uptake, plasma pH and GFR, etc. The polynomial equation P = aiHRi was used for illustrating the relationship between the physiological parameters (P) and heart rate (HR), which served as an index of exercise intensity. The pharmacokinetics of midazolam, quinidine, digoxin, and lidocaine during exercise were predicted by a whole-body physiologically based pharmacokinetic (WB-PBPK) model and the developed database of physiological parameters following administration to 100 virtual subjects. The WB-PBPK model simulation results showed that most of the observed plasma drug concentrations fell within the 5th–95th percentiles of the simulations, and the estimated peak concentrations (Cmax) and area under the curve (AUC) of drugs were also within 0.5–2.0 folds of observations. Sensitivity analysis showed that exercise intensity, exercise duration, medication time, and alterations in physiological parameters significantly affected drug pharmacokinetics and the net effect depending on drug characteristics and exercise conditions. In conclusion, the pharmacokinetics of drugs during exercise could be quantitatively predicted using the developed WB-PBPK model and database of physiological parameters.

SIGNIFICANCE STATEMENT

This study simulated real-time changes of human physiological parameters during exercise in the WB-PBPK model and comprehensively investigated pharmacokinetic changes during exercise following oral and intravenous administration. Furthermore, the factors affecting pharmacokinetics during exercise were also revealed.




drugs

Early Prediction and Impact Assessment of CYP3A4-Related Drug-Drug Interactions for Small-Molecule Anticancer Drugs Using Human-CYP3A4-Transgenic Mouse Models [Articles]

Early detection of drug-drug interactions (DDIs) can facilitate timely drug development decisions, prevent unnecessary restrictions on patient enrollment, resulting in clinical study populations that are not representative of the indicated study population, and allow for appropriate dose adjustments to ensure safety in clinical trials. All of these factors contribute to a streamlined drug approval process and enhanced patient safety. Here we describe a new approach for early prediction of the magnitude of change in exposure for cytochrome P450 (P450) CYP3A4-related DDIs of small-molecule anticancer drugs based on the model-based extrapolation of human-CYP3A4-transgenic mice pharmacokinetics to humans. Victim drugs brigatinib and lorlatinib were evaluated with the new approach in combination with the perpetrator drugs itraconazole and rifampicin. Predictions of the magnitude of change in exposure deviated at most 0.99- to 1.31-fold from clinical trial results for inhibition with itraconazole, whereas exposure predictions for the induction with rifampicin were less accurate, with deviations of 0.22- to 0.48-fold. Results for the early prediction of DDIs and their clinical impact appear promising for CYP3A4 inhibition, but validation with more victim and perpetrator drugs is essential to evaluate the performance of the new method.

SIGNIFICANCE STATEMENT

The described method offers an alternative for the early detection and assessment of potential clinical impact of CYP3A4-related drug-drug interactions. The model was able to adequately describe the inhibition of CYP3A4 metabolism and the subsequent magnitude of change in exposure. However, it was unable to accurately predict the magnitude of change in exposure of victim drugs in combination with an inducer.




drugs

The surprising mental health and brain benefits of weight-loss drugs

Drugs like Ozempic and Wegovy have unexpected effects on the brain, opening up potential new ways to treat depression, anxiety, addiction and Alzheimer’s




drugs

Most effective migraine drugs revealed by review of trial data

A meta-analysis of 137 clinical trials finds triptan drugs are among the most effective for treating migraines, while newer ditan and gepant drugs were rated less highly




drugs

Weight-loss drugs lower impulse to eat – and perhaps to exercise too

Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and drugs – and now there’s evidence that it might make exercise less rewarding, too




drugs

Voters Just Said No to Drugs: Why legalization lost at the ballot box...


Voters Just Said No to Drugs: Why legalization lost at the ballot box...


(Third column, 4th story, link)


Drudge Report Feed needs your support!   Become a Patron




drugs

Telangana DCA warns private hospitals of stern action for illegal sale of narcotic drugs

Finding regulatory violations in two private hospitals operating in the twin cities of Hyderabad and Secunderabad, the Telangana drugs control administration (DCA) has issued advisories to all the private hospitals in the state mandating strict obtainment of NDPS licence (NDPS Form II) from the DCA to purchase and sell NDPS drugs.




drugs

What does the FDA do after drugs are approved? (15 seconds)

The U.S. Food and Drug Administration posted a video:

What happens after a drug is approved? And how and why do drug recalls happen? Learn more in this short video from FDA’s Center for Drug Evaluation and Research (CDER).




drugs

What does the FDA do after drugs are approved? (30 seconds)

The U.S. Food and Drug Administration posted a video:

What happens after a drug is approved? And how and why do drug recalls happen? Learn more in this short video from FDA’s Center for Drug Evaluation and Research (CDER).




drugs

What is FDA’s role in regulating drugs? (15 seconds)

The U.S. Food and Drug Administration posted a video:

The FDA oversees prescription, generic, biosimilars, and over-the-counter drugs. But what is the FDA’s role when it comes to drug regulation? Learn more in this short video from FDA’s Center for Drug Evaluation and Research (CDER).




drugs

What is FDA’s role in regulating drugs? (30 seconds)

The U.S. Food and Drug Administration posted a video:

The FDA oversees prescription, generic, biosimilars, and over-the-counter drugs. But what is the FDA’s role when it comes to drug regulation? Learn more in this short video from FDA’s Center for Drug Evaluation and Research (CDER).




drugs

How does the FDA approve new drugs? (15 seconds)

The U.S. Food and Drug Administration posted a video:

Prescription drugs go through many steps and phases before they’re approved by the FDA, from research to clinical trials. What does this process look like from beginning to end? Learn more in this short video from FDA’s Center for Drug Evaluation and Research (CDER).




drugs

How does the FDA approve new drugs? (30 seconds)

The U.S. Food and Drug Administration posted a video:

Prescription drugs go through many steps and phases before they’re approved by the FDA, from research to clinical trials. What does this process look like from beginning to end? Learn more in this short video from FDA’s Center for Drug Evaluation and Research (CDER).




drugs

Orphan Drugs at 30: Will Success Become Too Expensive?

The Orphan Drug Act (ODA) turned 30 this month, demonstrating that good laws really can have an enduring impact. Amidst the celebrations, a reporter asked me a provocative question: can we afford more orphan drugs costing hundreds of thousands of dollars per year? FDA Matters answered “yes.” However, I added a caveat that should worry everyone eager for orphan drugs to succeed. When genomics and personalized medicine become successful, this will multiply the number of rare diseases and the overall cost of orphan drugs, perhaps beyond what the system can bear.




drugs

Top nine biological drugs by sales in 2023

<p>The global biologicals market surged to an impressive US$419.07 billion in 2023. Blood and blood products led the market, commanding a dominant 66% share. Oncology stood out as the leading application segment, accounting for 36% of the market. North America held the largest revenue share, at 46%, while the Asia-Pacific region emerged as a rising star, poised to be the fastest-growing region over the next decade.</p>




drugs

Counterfeit Drugs in Clinical Trials?

This morning I ran across a bit of a coffee-spitter: in the middle of an otherwise opaquely underinformative press release fromTranscelerate Biopharma about the launch of their

Counterfeits flooding
the market? Really?
"Comparator Network" - which will perhaps streamline member companies' ability to obtain drugs from each other for clinical trials using active comparator arms -  the CEO of the consortium, Dalvir Gill, drops a rather remarkable quote:

"Locating and accessing these comparators at the right time, in the right quantities and with the accompanying drug stability and regulatory information we need, doesn't always happen efficiently. This is further complicated by infiltration of the commercial drug supply chain by counterfeit drugs.  With the activation of our Comparator Network the participating TransCelerate companies will be able to source these comparator drugs directly from each other, be able to secure supply when they need it in the quantities they need, have access to drug data and totally mitigate the risk of counterfeit drugs in that clinical trial."

[Emphasis added.]

I have to admit to being a little floored by the idea that there is any sort of risk, in industry-run clinical trials, of counterfeit medication "infiltration".

Does Gill know something that the rest of us don't? Or is this just an awkward slap at perceived competition – innuendo against the companies that currently manage clinical trial comparator drug supply? Or an attempt at depicting the trials of non-Transcelerate members as risky and prone to fraud?

Either way, it could use some explaining. Thinking I might have missed something, I did do a quick literature search to see if I could come across any references to counterfeits in trials. Google Scholar and PubMed produced no useful results, but Wikipedia helpfully noted in its entry on counterfeit medications:

Counterfeit drugs have even been known to have been involved in clinical drug trials.[citation needed]


And on that point, I think we can agree: Citation needed. I hope the folks at Transcelerate will oblige.




drugs

What Might the Future of Prescription Drugs Look Like Under Trump?

Experts agree that the incoming Trump administration will likely shake things up in the prescription drug world — most notably when it comes to research and development, drug pricing and PBM reform.

The post What Might the Future of Prescription Drugs Look Like Under Trump? appeared first on MedCity News.




drugs

NHRC notice to Health Ministry over shortage of HIV drugs




drugs

We are the Knifedads! Take a SLICE out of DRUGS!

Knifedads and youtube celebrities Karate Johnathan and Steeliest Daniel train the Appleton County High Security Elementary School on resisting drugs and witchcraft.




drugs

New Mechanism for Identifying Drugs for Dengue Discovered

New mechanism for designing antiviral drugs for dengue virus has been identified. The study details are published in iProceedings of the National Academy of Sciences/i.




drugs

Arthritis Drugs may Ward Off Long COVID Symptoms

Common drugs used to treat medlinkrheumatoid arthritis/medlink can relieve long COVID symptoms, suggests a new study led by University of Virginia




drugs

From Party Drugs to Healing Tools - The Promise of Psychedelic Therapy!

medlinkPsychedelics/medlink, previously known as dangerous party drugs, are now being explored as addiction treatments, but extensive research is




drugs

Do Diabetic Drugs Affect Mental Health

Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used in the treatment of medlinktype 2 diabetes/medlink and medlinkobesity/medlink.




drugs

Cardiac and Antimalarial Drugs Fuel Indian Pharma Market Growth

medlinkCardiac/medlink, antimalarial, and gastrointestinal therapies have fueled a 6% growth in India's pharmaceutical market in August. h2Indian




drugs

Quality Lapse in Generic Drugs: Alerts Issued by Regulatory Agency

More than 15 generic medications, including injectables and tablets, have been debarred since January by Tamil Nadu Medical Services Corporation (TNMSC).